PTC THERAPEUTICS, INC. — Director's Dealing 2015

Mar 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-03-10

Reporting Person: Almstead Neil Gregory (EVP, Research and CMC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-10	Common Stock	S	79	$70.71	Disposed	1295	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	29881	Direct

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the spouse of the reporting person on August 15, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.58 to $71.05 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.